Latest Cash Flow Management News

NT Minerals Limited reported a net cash outflow of $186,000 for the December quarter, ending with just $2,000 in cash but retaining $1.56 million in undrawn financing facilities.

Dateline Resources Limited’s latest quarterly report reveals a sharp decline in cash reserves, underscoring the company’s urgent need to secure additional funding to sustain its exploration activities.

AdNeo reported a standout quarter with record new sales led by its US-based Art of Mentoring division and significant operational cost reductions, positioning the company for growth through strategic acquisitions.

Nagambie Resources Limited reported a tightening cash position in its December 2024 quarter but maintains confidence in ongoing operations backed by over $1 million in available funding.

Simble Solutions reports a robust Q4 FY24 with a 117% jump in customer receipts and a strategic $280k capital placement, underpinning its growth in energy and sustainability software.

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Dreadnought Resources reported a challenging quarter with significant exploration spending and a tight cash position, yet remains confident in its operational outlook and funding prospects.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.

Nutritional Growth Solutions reported a slight revenue decline in Q4 FY24 but remains optimistic about growth and profitability in FY25, buoyed by renewed Walmart partnerships and expanding Asian distribution.

Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.

Electro Optic Systems (EOS) has completed the divestment of its EM Solutions subsidiary for $158.6 million, wiping out all borrowings and positioning itself with a strong cash balance of approximately $128 million. The company is actively pursuing significant defence contracts and expanding its manufacturing footprint.

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.